|
Tons of blog/niche content and PLR articles for just $17.00! Check this out... you'll be surprised!
Welcome to Article Realm - Free Article Directory - Free Articles!
Articles » Disease-&-Illness » Breast-Cancer >> View Article
|
|
Forex Trading Made Easy
Excellent guide for beginners of forex trading... read more
Forex Easy Cash
Profitable software that brings you thousands of dollars each day... read more
Analytical Forex Software
Generate your own forex signals for profitable trading!... read more
Short Term Forex Trading
improve your forex trading results with new strategies.... read more
Forex Loophole System
No trading experience required, easy profit, perfect for beginners... read more
|
|
|
 |
|
 |
| Glutamate: Brain "Glu" Gets You in a Sticky Situation |
By:
Stephen Jones |
|
Glutamate is the major excitatory neurotransmitter in the mammalian brain, and is released into the synaptic cleft by most neurons when they send signals to other neurons in the brain. Glutamate exerts its actions by binding to several classes of glutamate receptors which leads to a complex network of downstream signaling events. Overall, glutamate and other neurotransmitter signaling events rely heavily on protein phosphorylation which fuels signal transduction cascades. The increasing availability of phosphospecific antibodies to components in transmitter networks is enabling researchers to define and map complex signaling pathways.
Glutamate signaling plays a pivotal role in many physiological functions including learning and remembering. However, the “glu” that binds is also a potent neurotoxin and is increasingly being implicated in the pathogenesis of neurological diseases including stroke, head trauma, epilepsy, AIDs, Hungtington’s, Parkinson’s and Alzheimer’s disease. For example, during stroke and following head trauma, neurons release massive amounts of glutamate onto nearby neurons which become overexcited, overloaded with calcium and undergo apoptosis. Inhibiting neuronal cell death with glutamate receptor blockers is an emerging therapeutic strategy for managing glutamate-related diseases, and dozens of blockers are now in research or clinical studies. See below for our Glutamate-related products.
Author Information
IMGENEX India Pvt Ltd. the only biotech company in Orissa and one of its kinds in Eastern India. IMGENEX India started in Oct as an outsourcing branch of IMGENEX Corporation,San Diego, USA. Find out more information about Adenosine A2a. |
|
|
 |
 |
 |
 |
|
|
